US Broker Ratings

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling serious diseases. Operating out of..

Varex Imaging Corporation (VREX) Investor Outlook: 21.55% Potential Upside and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, Varex Imaging Corporation (NASDAQ: VREX) presents an intriguing proposition. With a market capitalization of $593.16 million, Varex operates..

Sprout Social, Inc (SPT) Stock Analysis: A Look at Its 64% Potential Upside in a Competitive Market

Sprout Social, Inc. (NYSE: SPT), with its current stock price at $9.51, presents an intriguing opportunity for investors, particularly given its potential upside of 64.04% based..

Gossamer Bio, Inc. (GOSS) Investor Outlook: Biotech Stock Poised for 246.72% Upside with Promising PAH Treatment

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company that has captured the attention of investors with its innovative approach to treating pulmonary arterial hypertension..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Gem with 95.98% Potential Upside

Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company, has caught the attention of investors with its impressive potential upside of nearly 96%. Operating in the healthcare..

Neurogene Inc. (NGNE) Stock Analysis: Unpacking a 222% Upside Potential in Biotechnology

Neurogene Inc. (NASDAQ: NGNE), a promising player in the biotechnology sector, is catching the attention of investors with its substantial upside potential of 222.23%. Specializing in..

Cartesian Therapeutics, Inc. (RNAC): Stock Analysis Reveals a Staggering 365% Potential Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing the attention of investors in the biotechnology sector, driven by its innovative approach to mRNA cell therapies for autoimmune..

Marti Technologies, Inc. (MRT): An Investor Outlook on a High-Growth, High-Upside Turkish Tech Innovator

Marti Technologies, Inc. (NASDAQ: MRT), a burgeoning player in Turkey’s urban mobility landscape, is capturing investor interest with its impressive revenue growth and substantial potential upside...

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring the 161.64% Potential Upside in the Medical Devices Sector

Senseonics Holdings, Inc. (SENS) stands at a captivating juncture in the healthcare sector, particularly within the medical devices industry. This Germantown, Maryland-based company is making significant..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 110% Upside in the EdTech Arena

Investors with an eye on the educational technology sector should take note of Nerdy Inc. (NRDY), a company that has carved out a niche in live..

Aurora Cannabis Inc. (ACB): Investor Outlook with a 48.89% Potential Upside

Aurora Cannabis Inc. (NYSE: ACB), a prominent player in the healthcare sector specializing in the production and distribution of cannabis products, presents a compelling opportunity for..

Mereo BioPharma Group plc (MREO): Exploring a Potential 552.95% Upside in Biotech’s Tumultuous Terrain

For investors with a keen eye on the biotechnology sector, Mereo BioPharma Group plc (NASDAQ: MREO) is a name that might warrant your attention. With a..

SoundHound AI, Inc. (SOUN) Stock Analysis: Navigating a 53.6% Potential Upside Amidst Rising AI Demand

SoundHound AI, Inc. (NASDAQ: SOUN) stands at the forefront of the burgeoning voice AI industry, presenting a fascinating opportunity for investors keen on capitalizing on the..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Exploring a 71.82% Potential Upside with Innovative Biotech Solutions

Investors seeking opportunities in the biotechnology sector may find Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) an intriguing prospect. With a market capitalization hovering at approximately $468.64 million,..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating Challenges with Strategic Innovation

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a notable player in the healthcare sector, is making waves with its cutting-edge sequencing technologies. Based in Menlo Park,..

Porch Group, Inc. (PRCH) Stock Analysis: Exploring a 118.94% Potential Upside

Porch Group, Inc. (NASDAQ: PRCH) is capturing the attention of investors with its innovative approach to the technology sector, particularly within the software application industry. With..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a Potential 514% Upside and Innovative Biotech Prospects

aTyr Pharma, Inc. (NASDAQ: ATYR) is making waves in the biotech sector with its groundbreaking approach to treating fibrosis and inflammatory diseases. Although the company is..

Neuronetics, Inc. (STIM) Stock Analysis: A Healthcare Gem with a 226% Upside

In the competitive landscape of healthcare, Neuronetics, Inc. (STIM) is making waves as a promising player within the medical devices industry. Specializing in neurohealth treatments, this..

Absci Corporation (ABSI): Investor Outlook on a Potential 166% Upside in AI-Driven Biotech

Absci Corporation (NASDAQ: ABSI), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug creation. This Vancouver-based..

Exxon Mobil Corporation (XOM) Investor Outlook: Navigating Market Volatility with Strategic Insights

Exxon Mobil Corporation (NYSE: XOM), a global titan in the energy sector, has long been an integral player in the oil & gas integrated industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds